Unlike COVID-19, Mpox didn’t spark immediate worldwide lockdowns. There were no international travel bans or sweeping mask mandates. But for ...

When U.S. troops were deployed to Iraq in the early 2000s, few could have imagined that the very air they ...

There is a subtle but dangerous form of misinformation spreading — not loud and conspiratorial, but quiet and insidious. It’s ...

In the early days of the Gaza-Israel conflict, images of devastation filled screens and newspapers around the world. Hospitals overwhelmed, ...

A small, wiry cough. A child’s flushed cheeks. A worried parent clutching an ER intake clipboard. These are the moments ...

The narrative around COVID-19 and children has long been shaped by a sense of guarded relief. While adults—particularly the elderly ...

There’s a quiet revolution happening in the disability services sector—one that is rarely covered in mainstream media but carries far-reaching ...

In 1910, Abraham Flexner published a report that would forever alter the course of American medicine. Commissioned by the Carnegie ...

The American healthcare system is quietly undergoing a financial transformation. As insurance premiums rise and administrative complexity deepens, more patients—and ...

Cardiologists and neurologists have long viewed atrial fibrillation (AFib) and dementia as two distinct clinical challenges. But a growing body ...

The news of 23andMe’s financial instability and potential bankruptcy isn’t just another tech-company flameout. It’s a watershed moment for the ...

As the U.S. retools its trade policies in an increasingly fractured global economy, tariffs—once seen as abstract economic levers—are becoming ...